About Hongbo Lu
Hongbo Lu is a director at Zenas BioPharma.
Form D filings also name Hongbo Lu as a director at BlossomHill Therapeutics and ADARx Pharmaceuticals.
Hongbo Lu reports to the SEC as a director of 5 public companies, including Arrowhead Pharmaceuticals (ARWR), Terns Pharmaceuticals (TERN) and Avedro (AVDR).
Hongbo Lu first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Hongbo Lu in the role, so the role may have started earlier or lasted longer.
AI
Arrowhead Pharmaceuticals, Inc.
Director
2024 – 2026 · Public company (ARWR)
TI
Terns Pharmaceuticals, Inc.
Director
2021 – 2025 · Public company (TERN)
AI
Avedro Inc.
Director
2019 · Public company (AVDR)
TI
Turning Point Therapeutics, Inc.
Director
2019 · Public company (TPTX)
Key Colleagues at Startups
The people Hongbo Lu works with at each company, as listed on that company's latest Form D.
Zenas BioPharma, Inc. · Form D, May 14, 2024
PE
Patrick Enright
Director
TK
Tomas Kiselak
Director
PA
Patricia Allen
Director
JF
Joseph Farmer
PRESIDENT and CHIEF OPERATING OFFICER
LJ
Leon Moulder, Jr.
Executive officer and director
JN
Jake Nunn
Director
TX
Tim Xiao
Director
JF
Jennifer Fox
Executive officer
JB
James Boylan
Director
TF
Tanya Fischer
Executive officer
JO
John Orloff
Director
BlossomHill Therapeutics, Inc. · Form D, Jan 2, 2024
SA
Sundeep Agrawal
Director
JC
Jingrong Jean Cui
President and Chief Executive Officer, director
BC
Bihua Chen
Director
GL
George Lee
Director
CG
Carl Gordon
Director
YL
Yishan Li
Executive officer and director
ADARx Pharmaceuticals, Inc. · Form D, Nov 17, 2020
ZL
Zhen Li
President & CEO, director
RZ
Rui Zhu
Executive officer
CG
Carl Gordon
Director
Erez Chimovits
Director
SG
Sheila Gujrathi
Director